Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Australia;
Surveillance, Epidemiology and Research Programs, Kirby Institute, UNSW Sydney, Australia.
Public Health Res Pract. 2022 Mar 10;32(1):31502119. doi: 10.17061/phrp31502119.
The incidence of skin cancer, including melanoma, continues to climb in white populations around the world, imposing a large and growing burden on health systems and individuals. Harmful exposure to ultraviolet (UV) radiation, mostly solar UV, is the most avoidable cause of skin cancer risk and mortality. Many economic evaluations attest to the favourable benefits for governments and citizens from skin cancer prevention programs. This overview presents the current 'state of play' of the economics of skin cancer prevention. More research is required to document contemporary costs of managing skin cancer in Australia and New Zealand to accurately assess the true savings from primary prevention. New directions are proposed for ways that economics could contribute to the investment case for prevention. The majority of skin cancers are avoidable and curable, yet cost the Australian health economy A$1.7 billion each year. Therefore primary prevention of skin cancers must remain high on the public health agenda.
皮肤癌（包括黑色素瘤）的发病率在世界各地的白种人群中持续攀升，给卫生系统和个人带来了巨大且不断增长的负担。有害的紫外线（UV）辐射暴露，主要是太阳紫外线，是导致皮肤癌风险和死亡率的最可避免的原因。许多经济评估证明了皮肤癌预防计划对政府和公民的有利益处。本综述介绍了皮肤癌预防经济学的当前“现状”。需要进一步的研究来记录澳大利亚和新西兰管理皮肤癌的当代成本，以准确评估初级预防的真正节省。为了提出预防投资案例，提出了经济学可以做出贡献的新方向。大多数皮肤癌是可以预防和治愈的，但每年要耗费澳大利亚卫生经济 17 亿澳元。因此，皮肤癌的初级预防必须继续成为公共卫生议程的重中之重。
